Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

930 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infections in baricitinib clinical trials for patients with active rheumatoid arthritis.
Winthrop KL, Harigai M, Genovese MC, Lindsey S, Takeuchi T, Fleischmann R, Bradley JD, Byers NL, Hyslop DL, Issa M, Nishikawa A, Rooney TP, Witt S, Dickson CL, Smolen JS, Dougados M. Winthrop KL, et al. Among authors: nishikawa a. Ann Rheum Dis. 2020 Oct;79(10):1290-1297. doi: 10.1136/annrheumdis-2019-216852. Epub 2020 Aug 11. Ann Rheum Dis. 2020. PMID: 32788396 Free article.
Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials.
Harigai M, Takeuchi T, Smolen JS, Winthrop KL, Nishikawa A, Rooney TP, Saifan CG, Issa M, Isaka Y, Akashi N, Ishii T, Tanaka Y. Harigai M, et al. Among authors: nishikawa a. Mod Rheumatol. 2020 Jan;30(1):36-43. doi: 10.1080/14397595.2019.1583711. Epub 2019 Mar 21. Mod Rheumatol. 2020. PMID: 30784354 Clinical Trial.
Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1).
Imafuku S, Torisu-Itakura H, Nishikawa A, Zhao F, Cameron GS; Japanese UNCOVER-1 Study Group. Imafuku S, et al. Among authors: nishikawa a. J Dermatol. 2017 Nov;44(11):1285-1290. doi: 10.1111/1346-8138.13927. Epub 2017 Jun 21. J Dermatol. 2017. PMID: 28635026 Free PMC article. Clinical Trial.
Active and passive smoking and risk of ulcerative colitis: A case-control study in Japan.
Nishikawa A, Tanaka K, Miyake Y, Nagata C, Furukawa S, Andoh A, Yokoyama T, Yoshimura N, Mori K, Ninomiya T, Yamamoto Y, Takeshita E, Ikeda Y, Saito M, Ohashi K, Imaeda H, Kakimoto K, Higuchi K, Nunoi H, Mizukami Y, Suzuki S, Hiraoka S, Okada H, Kawasaki K, Higashiyama M, Hokari R, Miura H, Miyake T, Kumagi T, Kato H, Hato N, Sayama K, Hiasa Y; Japan Ulcerative Colitis Study Group. Nishikawa A, et al. J Gastroenterol Hepatol. 2022 Apr;37(4):653-659. doi: 10.1111/jgh.15745. Epub 2021 Dec 13. J Gastroenterol Hepatol. 2022. PMID: 34845747
930 results